Level of Maternal Antibody Required to Protect Neonates against Early‐Onset Disease Caused by Group B Streptococcus Type Ia: A Multicenter, Seroepidemiology Study
Year: 2001
Type: article
Study design: Observational Study
DOI: 10.1086/323350
Institutions: National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, University of Alabama at Birmingham, Baylor College of Medicine, University of Florida Health, University of Florida, University of Medicine and Dentistry of New Jersey, Columbia University, Center for Biologics Evaluation and Research, United States Food and Drug Administration, Westat (United States)
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Awards: STREPTOCOCCAL DISEASE IN NEONATES, G1973336932, G1989764641, STREPTOCOCCAL DISEASE IN NEONATES, STREPTOCOCCAL DISEASE IN NEONATES, STREPTOCOCCAL DISEASE IN NEONATES, STREPTOCOCCAL DISEASE IN NEONATES, G3743395638, G4750898037, G4881379320, G7202566069, G7801181260, DATA COORDINATING CENTER FOR VACCINE EVALUATION
OpenAlex ID: W2157517505
